We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Sharookh B Kapadia - Senior Principal Scientist, Infectious Diseases

Sharookh B Kapadia

Senior Principal Scientist, Infectious Diseases

Postdoc Mentor
"There is no better place than Genentech where collaborating with colleagues to develop innovative therapeutics for patients is so inspiring and fun."
Years at Genentech
Publications at Genentech
Awards & Honors

I joined the Department of Infectious Diseases at Genentech (called the Department of Microbial Pathogenesis at the time) as a Scientist in 2007. Primarily trained in Virology and Immunology, we were initially tasked with establishing an anti-Hepatitis C Virus (HCV) program. Since then, we have been focused on better understanding bacterial pathogenesis and biology in order to identify novel targets for therapeutic intervention.

What initially attracted me to Genentech and still keeps me engaged to this day is the unrelenting collaborative and unselfish nature of the scientists whom I have the privilege of working with every day. In addition, a solid research infrastructure and commitment to rigorous science pushes me to uncover transformative biology that could help the development of better and safer therapies for patients.

Postdoctoral Mentor

I have been very lucky to have been trained by truly outstanding scientists and mentors during my training as an undergraduate, graduate and postdoctoral fellow, and these experiences have made me really appreciate the value of a good mentor and how they can shape the way a scientist thinks once they move on to their independent career. Being a postdoc mentor is a very rewarding experience for me and I hope to transfer some of the knowledge and experiences I learned as a trainee to the next generation of scientists and drug discoverers.

Featured Publication

Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate.

MBio. 2017 May 23;8(3). pii: e00603-17.

Diao J, Bouwman C, Yan D, Kang J, Katakam AK, Liu P, Pantua H, Abbas AR, Nickerson NN, Austin C, Reichelt M, Sandoval W, Xu M, Whitfield C, Kapadia SB.